Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.245
-0.255 (-17.00%)
At close: Nov 15, 2024, 4:00 PM
1.450
+0.205 (16.47%)
After-hours: Nov 15, 2024, 6:40 PM EST
Cue Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -44.61 | -50.73 | -53.01 | -44.16 | -44.78 | -36.7 | Upgrade
|
| Depreciation & Amortization | 3.44 | 3.44 | 1.81 | 1.26 | 1.06 | 0.81 | Upgrade
|
| Other Amortization | 0.04 | 0.04 | 0.03 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.06 | 0.16 | 0 | -0.02 | - | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.23 | -0.32 | -0 | 0.08 | -0.07 | Upgrade
|
| Stock-Based Compensation | 7.36 | 8.18 | 9.5 | 11.52 | 10.48 | 6.52 | Upgrade
|
| Other Operating Activities | 0.13 | 0.13 | -0.17 | -3.04 | -4.77 | - | Upgrade
|
| Change in Accounts Receivable | -1.49 | -1.64 | 3.09 | -1.73 | -0.66 | -0.75 | Upgrade
|
| Change in Accounts Payable | 3.99 | 0.77 | 0.08 | 0.52 | 0.74 | -1.15 | Upgrade
|
| Change in Unearned Revenue | -1.98 | 2.11 | -0.65 | -7.97 | 0.5 | - | Upgrade
|
| Change in Other Net Operating Assets | -5.19 | -2.18 | -2.17 | 4.79 | 4.85 | 0.5 | Upgrade
|
| Operating Cash Flow | -38.26 | -39.96 | -41.81 | -38.84 | -32.49 | -30.8 | Upgrade
|
| Capital Expenditures | -0.06 | - | -0.17 | -0.91 | -0.6 | -0.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.1 | 0 | 0.01 | 0.02 | - | 0.13 | Upgrade
|
| Investment in Securities | - | 25 | -24.45 | 10 | 5.05 | 3.37 | Upgrade
|
| Investing Cash Flow | 0.03 | 25 | -24.61 | 9.11 | 4.46 | 3.45 | Upgrade
|
| Long-Term Debt Issued | - | - | 10 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -4 | -2 | 10 | - | - | - | Upgrade
|
| Issuance of Common Stock | 19.96 | 13.86 | 39.3 | 19.98 | 58.89 | 50.88 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.2 | -0.75 | -0.27 | -0.09 | Upgrade
|
| Other Financing Activities | - | - | 4.56 | - | - | - | Upgrade
|
| Financing Cash Flow | 15.96 | 11.86 | 53.66 | 19.23 | 58.61 | 50.79 | Upgrade
|
| Net Cash Flow | -22.27 | -3.1 | -12.76 | -10.5 | 30.58 | 23.44 | Upgrade
|
| Free Cash Flow | -38.32 | -39.96 | -41.98 | -39.75 | -33.09 | -30.84 | Upgrade
|
| Free Cash Flow Margin | -402.05% | -727.89% | -3371.65% | -266.04% | -1049.01% | -891.85% | Upgrade
|
| Free Cash Flow Per Share | -0.77 | -0.87 | -1.18 | -1.27 | -1.15 | -1.40 | Upgrade
|
| Cash Interest Paid | 1 | 1 | 0.57 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.5 | - | 0.41 | Upgrade
|
| Levered Free Cash Flow | -19.57 | -20.2 | -21.09 | -20.32 | -13.58 | -14.92 | Upgrade
|
| Unlevered Free Cash Flow | -18.89 | -19.46 | -20.68 | -20.32 | -13.58 | -14.92 | Upgrade
|
| Change in Net Working Capital | 1.92 | -1.42 | -1.63 | 5.12 | -3.29 | -0.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.